타우린 관련 불면증

Q: Does 타우린 help with 불면증?

Based on 11 studies with 32 participants, there is moderate evidence from clinical studies that 타우린 may support 불면증 management. Our evidence grade is B (Good Evidence).

Q: How much 타우린 should I take for 불면증?

Studies have used various dosages. A commonly studied range is 500-2,000 mg, 1 hour before bed. Always consult your healthcare provider before starting any supplement regimen.

Q: Are there side effects of 타우린?

Reported side effects may include Generally well tolerated, Mild GI discomfort at high doses, Drowsiness (desired for sleep use). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

Q: How strong is the evidence for 타우린 and 불면증?

We rate the evidence as Grade B (Good Evidence). This rating is based on 11 peer-reviewed studies with 32 total participants. The overall direction of effect is mixed.

B 근거 적어도 하나의 무작위 시험이 이를 지지하며, 대체로 일관된 결과를 보입니다.

Taurine은 뇌에서 GABA-A 및 glycine 수용체를 조절하는 억제성 아미노산입니다. 전임상 연구에서 진정 및 항불안 효과가 입증되었습니다. 제한된 인체 데이터에 따르면 taurine이 특히 마그네슘이나 GABA와 병용할 때 수면의 질을 지원할 수 있습니다. 더 많은 임상 시험이 필요합니다.

𝕏 LinkedIn

<\/script>\n

`; }, get iframeSnippet() { const domain = 'sleepcited.com'; const params = 'ingredient\u003Dtaurine\u0026condition\u003Dinsomnia'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

결론

Key Study Findings

basic science

Lactobacillus reuteri E9 Regulates Sleep Disorders Through Its Metabolite GABA.

Dose: Lactobacillus reuteri E9 (dose not specified) vs: Placebo 효과: None < 0.05

Controlled Clinical Trial n=32 12 weeks Open-label

Efficacy and associated neurotransmitters of digital cognitive behavior therapy for atopic dermatitis: A comparative effectiveness …

Dose: None vs: Standard care alone Outcome: Itch and insomnia improvement in atopic dermatitis 효과: None 0.0449 (itch), 0.0089 (insomni

대상 집단: Patients with atopic dermatitis and mild-moderate negative emotions

Review

Commonly encountered symptoms and their management in patients with cirrhosis.

Dose: None vs: None Outcome: Pain outcomes 효과: None None

대상 집단: Insomnia patients

Other

Energy drinks in Tamale: Understanding youth perceptions, consumption patterns, and related factors.

Dose: None vs: None Outcome: None 효과: None p < .05

대상 집단: Insomnia patients

Observational Study

[Energy drink consumption patterns and its adverse effects on adolescent health.].

Dose: None vs: None Outcome: Energy drink consumption and adverse effects 효과: None None

대상 집단: Adolescents

Other

[Establishment of rat heart-kidney insomnia model consistent with traditional Chinese medicine syndrome and its serum …

Dose: None vs: None Outcome: rat model of cardiorenal insomnia from in vitro … 효과: None None

대상 집단: None

Key Statistics

연구

참여자

↔

Mixed

등급

Referenced Papers

Serum Amino Acid and Fatty Acid Metabolites as Predictors of Sleep Disorders in Children: A Risk Prediction Model. Other

Biomedicines 2026

Efficacy and associated neurotransmitters of digital cognitive behavior therapy for atopic dermatitis: A comparative effectiveness research. Other

Asian Pacific journal … 2025 6 인용

Lactobacillus reuteri E9 Regulates Sleep Disorders Through Its Metabolite GABA. Other

Frontiers in bioscience … 2025

Energy drinks in Tamale: Understanding youth perceptions, consumption patterns, and related factors. Other

PloS one 2024 5 인용

Commonly encountered symptoms and their management in patients with cirrhosis. Review

Frontiers in medicine 2024 4 인용

[Energy drink consumption patterns and its adverse effects on adolescent health.]. Other

Revista espanola de … 2022 2 인용

[Establishment of rat heart-kidney insomnia model consistent with traditional Chinese medicine syndrome and its serum metabolomics]. Other

Zhongguo Zhong yao … 2020 5 인용

Assessment and treatment of insomnia in adult patients with alcohol use disorders. Review

Alcohol (Fayetteville, N.Y.) 2015 122 인용

The clinical pharmacology of acamprosate. Review

British journal of … 2014 111 인용

Pharmacological treatment of insomnia in alcohol recovery: a systematic review. Systematic Review

Alcohol and alcoholism … 2011 40 인용

Safety issues associated with commercially available energy drinks. Review

Journal of the … 2008 300 인용

Suppressive effect of Yokukansan on excessive release of glutamate and aspartate in the hippocampus of zinc-deficient rats. Other

Nutritional neuroscience 2008 73 인용

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

일반적으로 사용되는 용량

sleep:: 500-2,000 mg, 1 hour before bed

상한량: 3,000 mg/day considered safe in clinical studies

연구에서 사용된 용량

용량	기간	효과	N
Lactobacillus reuteri E9 (dose not specified)	--	Positive	--
None	12 weeks	Positive	32
None	--	Neutral	--
None	--	Neutral	--
None	--	Mixed	--
None	--	Mixed	--
None	--	Positive	--
None	--	Positive	--

권장 복용 시간: 1 hour before bed

Safety & Side Effects

보고된 부작용

⚠ Generally well tolerated
⚠ Mild GI discomfort at high doses
⚠ Drowsiness (desired for sleep use)

알려진 상호작용

● Lithium — taurine may alter lithium excretion
● Antihypertensives — may have additive blood pressure lowering effects
● CNS depressants — potential additive sedative effects

일일 최대 섭취 허용량: 3,000 mg/day considered safe in clinical studies

건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.

Frequently Asked Questions

Does 타우린 help with 불면증?

Based on 11 studies with 32 participants, there is moderate evidence from clinical studies that 타우린 may support 불면증 management. Our evidence grade is B (Good Evidence).

How much 타우린 should I take for 불면증?

Studies have used various dosages. A commonly studied range is 500-2,000 mg, 1 hour before bed. Always consult your healthcare provider before starting any supplement regimen.

Are there side effects of 타우린?

Reported side effects may include Generally well tolerated, Mild GI discomfort at high doses, Drowsiness (desired for sleep use). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

How strong is the evidence for 타우린 and 불면증?

We rate the evidence as Grade B (Good Evidence). This rating is based on 11 peer-reviewed studies with 32 total participants. The overall direction of effect is mixed.

타우린 다른 건강 상태에 대한 근거

입면 장애 B 야간 통증성 수면 방해 B

한눈에 보기

Taurine은 뇌에서 GABA-A 및 glycine 수용체를 조절하는 억제성 아미노산입니다. 전임상 연구에서 진정 및 항불안 효과가 입증되었습니다. 제한된 인체 데이터에 따르면 taurine이 특히 마그네슘이나 GABA와 병용할 때 수면의 질을 지원할 수 …

Evidence Strength72%

High confidence

연구 분석

RCT (0)Meta (0)Other (11)

대안 비교

이 건강 상태에 대한 다른 성분의 비교 결과를 확인하세요.

모든 성분 보기: 불면증

자세히 알아보기

References

[1] Liuyan Zhu et al.. Biomedicines. 2026. Serum Amino Acid and Fatty Acid Metabolites as Predictors of Sleep Disorders in Children: A Risk Prediction Model. doi:10.3390/biomedicines14030546 PubMed
[2] Wanying Zhai et al.. Asian Pac J Allergy Immunol. 2025. Efficacy and associated neurotransmitters of digital cognitive behavior therapy for atopic dermatitis: A comparative effectiveness research. doi:10.12932/AP-100223-1542 PubMed
[3] Yongcheng Jiang et al.. Front Biosci (Landmark Ed). 2025. Lactobacillus reuteri E9 Regulates Sleep Disorders Through Its Metabolite GABA. doi:10.31083/FBL39587 PubMed
[4] Williams Kobik et al.. PLoS One. 2024. Energy drinks in Tamale: Understanding youth perceptions, consumption patterns, and related factors. doi:10.1371/journal.pone.0289391 PubMed
[5] Cyriac Abby Philips. Front Med (Lausanne). 2024. Commonly encountered symptoms and their management in patients with cirrhosis. doi:10.3389/fmed.2024.1442525 PubMed
[6] Paola Silva Maldonado et al.. Rev Esp Salud Publica. 2022. [Energy drink consumption patterns and its adverse effects on adolescent health.]. PubMed
[7] Yu-Han Yang et al.. Zhongguo Zhong Yao Za Zhi. 2020. [Establishment of rat heart-kidney insomnia model consistent with traditional Chinese medicine syndrome and its serum metabolomics]. doi:10.19540/j.cnki.cjcmm.20190524.502 PubMed
[8] Kirk J Brower. Alcohol. 2015. Assessment and treatment of insomnia in adult patients with alcohol use disorders. doi:10.1016/j.alcohol.2014.12.003 PubMed
[9] Nicola J Kalk et al.. Br J Clin Pharmacol. 2014. The clinical pharmacology of acamprosate. doi:10.1111/bcp.12070 PubMed
[10] Bhanu Prakash Kolla et al.. Alcohol Alcohol. 2011. Pharmacological treatment of insomnia in alcohol recovery: a systematic review. doi:10.1093/alcalc/agr073 PubMed
[11] Kevin A Clauson et al.. J Am Pharm Assoc (2003). 2008. Safety issues associated with commercially available energy drinks. doi:10.1331/JAPhA.2008.07055 PubMed
[12] Atsushi Takeda et al.. Nutr Neurosci. 2008. Suppressive effect of Yokukansan on excessive release of glutamate and aspartate in the hippocampus of zinc-deficient rats. doi:10.1179/147683008X301414 PubMed

FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.